AC
PTCT icon

Armistice Capital’s PTC Therapeutics PTCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$231M Sell
4,735,464
-699,379
-13% -$34.2M 3.99% 1
2025
Q1
$277M Sell
5,434,843
-943,157
-15% -$48.1M 4.15% 1
2024
Q4
$288M Sell
6,378,000
-856,898
-12% -$38.7M 3.93% 1
2024
Q3
$268M Buy
7,234,898
+272,671
+4% +$10.1M 4.29% 1
2024
Q2
$213M Buy
6,962,227
+198,227
+3% +$6.06M 2.68% 1
2024
Q1
$197M Sell
6,764,000
-100,000
-1% -$2.91M 2.61% 1
2023
Q4
$189M Buy
6,864,000
+714,000
+12% +$19.7M 2.58% 1
2023
Q3
$138M Buy
6,150,000
+2,914,000
+90% +$65.3M 2.11% 2
2023
Q2
$132M Buy
3,236,000
+312,000
+11% +$12.7M 1.9% 4
2023
Q1
$142M Sell
2,924,000
-472,000
-14% -$22.9M 2.04% 4
2022
Q4
$130M Buy
3,396,000
+496,000
+17% +$18.9M 2.26% 4
2022
Q3
$146M Sell
2,900,000
-396,000
-12% -$19.9M 2.53% 3
2022
Q2
$132K Buy
3,296,000
+260,000
+9% +$10.4K 2.3% 6
2022
Q1
$113M Buy
3,036,000
+2,118,893
+231% +$79.1M 2.19% 4
2021
Q4
$36.5M Sell
917,107
-1,678,893
-65% -$66.9M 0.6% 39
2021
Q3
$96.6M Buy
2,596,000
+504,000
+24% +$18.8M 1.64% 10
2021
Q2
$88.4M Buy
2,092,000
+696,000
+50% +$29.4M 1.58% 8
2021
Q1
$66.1M Buy
1,396,000
+680,000
+95% +$32.2M 1.52% 13
2020
Q4
$43.7M Sell
716,000
-8,000
-1% -$488K 1.49% 15
2020
Q3
$33.8M Buy
724,000
+224,000
+45% +$10.5M 1.23% 24
2020
Q2
$25.4M Sell
500,000
-100,000
-17% -$5.07M 1.11% 36
2020
Q1
$26.8M Sell
600,000
-158,000
-21% -$7.05M 1.66% 18
2019
Q4
$36.4M Buy
758,000
+622,000
+457% +$29.9M 2.1% 7
2019
Q3
$4.6M Buy
+136,000
New +$4.6M 0.3% 49
2019
Q2
Sell
-400,000
Closed -$15.1M 76
2019
Q1
$15.1M Buy
400,000
+100,000
+33% +$3.76M 0.82% 26
2018
Q4
$10.3M Buy
+300,000
New +$10.3M 0.78% 27